Induction of robust neutralizing antibodies against the COVID-19 Delta variant with ChAdOx1 nCoV-19 or BNT162b2 as a booster following a primary vaccination series with CoronaVac

Samadhi Patamatamkul, Sutthiwan Thammawat, Benjaporn Buranrat
doi: https://doi.org/10.1101/2021.09.25.21264099

Article usage

Article usage: September 2021 to December 2024

AbstractFullPdf
Sep 202110214378
Oct 20211036216428
Nov 2021960169190
Dec 20212657097
Jan 20221743953
Feb 2022972749
Mar 20221013240
Apr 2022682564
May 2022492129
Jun 2022562024
Jul 202251176
Aug 2022462116
Sep 2022511614
Oct 2022442217
Nov 2022361718
Dec 2022362320
Jan 2023321813
Feb 202324229
Mar 202322105
Apr 2023312115
May 2023182011
Jun 202319226
Jul 2023121911
Aug 2023233110
Sep 202359336
Oct 2023581811
Nov 2023362612
Dec 2023222112
Jan 202413216
Feb 202461206
Mar 202413206
Apr 202412208
May 2024191810
Jun 202417149
Jul 202421714
Aug 2024332511
Sep 2024181717
Oct 202426194
Nov 202419169
Dec 202413112
Back to top
Posted September 28, 2021.
Download PDF
Data/Code
Email
Induction of robust neutralizing antibodies against the COVID-19 Delta variant with ChAdOx1 nCoV-19 or BNT162b2 as a booster following a primary vaccination series with CoronaVac
Samadhi Patamatamkul, Sutthiwan Thammawat, Benjaporn Buranrat
medRxiv 2021.09.25.21264099; doi: https://doi.org/10.1101/2021.09.25.21264099
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area